Skin barrier dysfunction has been reported in both atopic dermatitis (AD) and food allergy (FA).

Malaria remains the most prevalent vector-borne infectious disease and
has the highest rates of fatality. Current antimalarial drug strategies
cure malaria or prevent infections but lack a sustained public health
impact because they fail to expedite the acquisition of protective